Lanean...

Conditioning with Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

In this prospective study 60 patients of median age 46 (range 5–60) years, with acute myeloid leukemia (AML; n=44), acute lymphoblastic leukemia (ALL; n=3), or myelodysplastic syndrome (MDS; n=13) were conditioned for allogeneic hematopoietic cell transplantation with a treosulfan/fludarabine combin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nemecek, Eneida R., Guthrie, Katherine A., Sorror, Mohamed L., Wood, Brent L., Doney, Kristine C., Hilger, Ralf A., Scott, Bart L., Kovacsovics, Tibor J., Maziarz, Richard T., Woolfrey, Ann E., Bedalov, Antonio, Sanders, Jean E., Pagel, John M., Sickle, Eileen J., Witherspoon, Robert, Flowers, Mary E., Appelbaum, Frederick R., Deeg, H. Joachim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974965/
https://ncbi.nlm.nih.gov/pubmed/20685259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.05.007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!